Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure.
Serwin
Agnieszka Beata
AB
Department of Dermatology and Venereology, Medical Academy of Białystok, Białystok, Poland.
Myśliwiec
Hanna
H
Laudańska
Halina
H
Chodynicka
Bozena
B
D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000150:complications* / Q000276:immunology*
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D007070:Immunoglobulin A; D003622:Dapsone; D011241:Prednisone